HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Class II For Recalls Of Potentially Listeria-Contaminated Nutritional Bars

This article was originally published in The Rose Sheet

Executive Summary

The agency's latest recall database updates also note an expansion of ProSupps USA LLC's class I recall of sports training beverages found to contain picamilon. Consumer health product recalls compiled from FDA's July 5 and 12 updates.

You may also be interested in...



ProSupps Expands Picamilon Recall To 18 More Products

ProSupps initiates recall of fitness powders and drinks that contain picamilon, an unapproved ingredient that crosses the blood-brain barrier.

Nutritional Bars Caught In Listeria-Contaminated Nut Ingredient Recalls

Bulletproof 360's recall announcement says HVF Inc. supplied potentially contaminated cashew butter used in its products, and GoMacro received almond ingredients for its products from HVF.

FDA Consumer Health Product Recalls For April 6

Recalls reported by FDA for OTC drugs, nutritionals and personal care products.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS121082

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel